Additionally, Osako et al. [31] reported a marked reduction of the miR-99a expression levels via regulation of ribonucleotide reductase regulatory subunit-M2 (RRM2) in sunitinib-resistant ccRCC cell lines. Here, RRM2 is linked to nonpapillary renal cell carcinoma.